Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01869725
What this trial is testing

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

Who this might be right for
Adult MedulloblastomaChildhood MedulloblastomaNeuroblastoma+2 more
Sue O'Dorisio 68
Testing effectiveness (Phase 2)Study completedNCT00191568
What this trial is testing

Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Eli Lilly and Company 45
Early research (Phase 1)Looking for participantsNCT06983743
What this trial is testing

ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Erasca, Inc. 600
Not applicableUnknownNCT05997147
What this trial is testing

A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Predictive Cancer ModelPancreas Cancer
Tianjin Medical University Cancer Institute and Hospital 1,009
Testing effectiveness (Phase 2)Study completedNCT05014776
What this trial is testing

Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Testing effectiveness (Phase 2)Ended earlyNCT03785210
What this trial is testing

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerMetastatic Pancreatic Cancer+2 more
National Cancer Institute (NCI) 22
Not applicableUnknownNCT01455610
What this trial is testing

Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study

Who this might be right for
Adenocarcinoma of Head of Pancreas
Meng Su Zeng 140
Testing effectiveness (Phase 2)Ended earlyNCT02315625
What this trial is testing

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

Who this might be right for
Neuroendocrine TumorsNeuroendocrine CarcinomaNeuroendocrine Neoplasms+2 more
National Cancer Institute (NCI) 16
Not applicableStudy completedNCT00369460
What this trial is testing

Changes in Muscle Tissue in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Case Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)UnknownNCT01394120
What this trial is testing

Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
Sofia Perea, Director Clinical Trials Unit. 60
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Not applicableLooking for participantsNCT07619391
What this trial is testing

MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Ohio State University Comprehensive Cancer Center 30
Not applicableEnded earlyNCT01359410
What this trial is testing

Reinforced Staple Line on Leak Rate in Distal Pancreatectomy

Who this might be right for
Pancreatic Neoplasms
Washington University School of Medicine 112
Not applicableStudy completedNCT07329920
What this trial is testing

Mesenchymal CTC Ratio Dynamics Predicts Response and Survival in Pancreatic Ductal Adenocarcinoma With Neoadjuvant/Conversion Therapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Circulating Tumor Cells (CTCs)Neoadjuvant Therapy
Guo ShiWei 300
Large-scale testing (Phase 3)Ended earlyNCT01900327
What this trial is testing

Neoadjuvant Treatment in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Universitätsklinikum Hamburg-Eppendorf 32
Testing effectiveness (Phase 2)UnknownNCT02529579
What this trial is testing

Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
Changhai Hospital 187
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Testing effectiveness (Phase 2)Study completedNCT02905578
What this trial is testing

Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

Who this might be right for
Pancreatic NeoplasmsCancer of PancreasCancer of the Pancreas+4 more
University of Iowa 40
Not applicableUnknownNCT02817308
What this trial is testing

Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas

Who this might be right for
Carcinoma, Pancreatic Ductal
Rambam Health Care Campus 100
Not applicableStudy completedNCT02347618
What this trial is testing

Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma
University of Rochester 18
Next Page